YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Precision gene editing can be achieved by base editing, nucleotide editing, or editing of small or large gene fragments. The specific mechanisms include various DNA repair pathways. Many precision ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.